comparemela.com

Latest Breaking News On - T cell engager - Page 5 : comparemela.com

The UK Medicines and Healthcare products Regulatory Agency

The UK Medicines and Healthcare products Regulatory Agency (MHRA), Australian Therapeutic Goods Administration (TGA) and Health Canada approve KIMMTRAK®.

Australia
Oxfordshire
United-kingdom
United-states
Canada
Rockville
Western-australia
Australian
Susanna-daniels
Immunocore-imm
John-bell
Joe-sacco

NovalGen announces compelling data from the Phase 1/2 Study

- First clinical data for NVG-111, a novel ROR1xCD3 bispecific antibody in patients with relapsed / refractory CLL and MCL - Early data demonstrates.

Mccormick-place
Illinois
United-states
Chicago
London
City-of
United-kingdom
American
Julia-wilson
Amit-nathwani
Parag-jasani
University-college-london-hospitals

European Commission Approves KIMMTRAK® (tebentafusp) for

PRESS RELEASE European Commission Approves KIMMTRAK® (tebentafusp) for the treatment of unresectable or metastatic uveal melanoma KIMMTRAK is the first.

Iceland
Norway
Australia
United-states
United-kingdom
Oxfordshire
Liechtenstein
Canada
Rockville
Western-australia
Australian
Sophie-piperno-neumann

Sutro Biopharma Reports Full Year 2021 Financial Results, Business Highlights, and Anticipated 2022 Milestones

/PRNewswire/ Sutro Biopharma, Inc. ("Sutro" or the "Company") (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused.

China
Germany
United-states
Canada
Sutro-biopharma
Maggie-beller
Anniej-chang
Bristol-myers-squibb
Sutro-xpress
Exchange-commission-on
Celgene-corporation
Exchange-commission

Sanofi to pay $1.2bn to acquire Amunix and its 'stealth' technology

Sanofi to pay $1.2bn to acquire Amunix and its 'stealth' technology
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

John-reed
Amunix-pharmaceuticals
Translate-bio
T-cell-engager
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.